Penciclovir

Penciclovir

Chemical structure of Penciclovir

Penciclovir is an antiviral drug used primarily for the treatment of herpes simplex virus infections. It is a nucleoside analog that inhibits viral DNA polymerase, thereby preventing the replication of viral DNA.

Mechanism of Action

Penciclovir is a guanine analog that is phosphorylated by viral thymidine kinase to its active form, penciclovir triphosphate. This active form competes with deoxyguanosine triphosphate for incorporation into viral DNA. Once incorporated, it acts as a chain terminator, halting DNA synthesis and thereby inhibiting viral replication.

Clinical Use

Penciclovir is primarily used in the treatment of herpes labialis, commonly known as cold sores, caused by Herpes Simplex Virus Type 1 (HSV-1). It is available as a topical cream and is applied directly to the affected area. The drug is effective in reducing the duration and severity of symptoms when applied at the onset of an outbreak.

Pharmacokinetics

Penciclovir is poorly absorbed when administered orally, which is why it is typically used as a topical agent. Its bioavailability is low, and it is primarily excreted unchanged in the urine. The drug has a half-life of approximately 2 to 3 hours in the body.

Side Effects

The most common side effects of penciclovir are local skin reactions, including redness, itching, and mild burning at the site of application. Systemic side effects are rare due to its limited absorption.

Related Drugs

Penciclovir is related to famciclovir, which is an oral prodrug that is converted to penciclovir in the body. Famciclovir is used for systemic treatment of herpes infections, including herpes zoster and genital herpes.

Related Pages

• Antiviral drug
• Herpes simplex virus
• Nucleoside analog
• Thymidine kinase